No Data
How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.
On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.
Announcement highlights | CHINA POWER's electricity sales volume increased by nearly 30% year-on-year in the first 11 months; WUXI APPTEC plans to sell its WuXi ATU Business in the USA and United Kingdom.
WUXI APPTEC plans to sell its WuXi ATU Business in the USA and United Kingdom; GF SEC's proprietary business can participate in carbon emission trading at legal trading venues within the territory.
Livzon Pharmaceutical Group Inc. (000513.SZ): Spent 5.4997 million yuan to repurchase 0.1457 million A-shares.
On December 25, Glonghui reported that Livzon Pharmaceutical Group Inc. (000513.SZ) announced the repurchase of 0.1457 million shares of its A-shares for the first time through centralized bidding on December 25, 2024, accounting for 0.02% of the company's total share capital. The highest purchase price was 37.97 yuan per share, and the lowest price was 37.50 yuan per share, with a total amount of funds used being 5.4997 million yuan (excluding transaction fees).
LIVZON PHARMA (01513.HK) spent 4.1397 million HKD to repurchase 0.1527 million shares on December 24.
According to a announcement on December 24 by LIVZON PHARMA (01513.HK), it spent 4.1397 million HKD to repurchase 0.1527 million shares on December 24, with a repurchase price per share ranging from 26.85 to 27.2 HKD.
LIVZON PHARMA (01513.HK) spent 5.66 million HKD to repurchase 0.211 million shares on December 23.
Gelonghui, December 23 - LIVZON PHARMA (01513.HK) announced that on December 23, it spent 5.66 million Hong Kong dollars to repurchase 0.211 million shares.
LIVZON PHARMA (01513.HK) spent 5.238 million Hong Kong dollars to buy back 0.195 million shares on December 20.
On December 20, Glonhui reported that LIVZON PHARMA (01513.HK) announced it repurchased 195,000 shares for HKD 5.238 million.
The Market Doesn't Like What It Sees From Livzon Pharmaceutical Group Inc.'s (SZSE:000513) Earnings Yet
No Data
